ARCHIVES

FDA News: ODAC Clears Photofrin For Microinvasive NSCLC

This article is from The Cancer Letter archive.

Vol. 23 No. 37 | September 26, 1997

Download PDF Visit The Full Archive

Related Articles

Trials Approved by NCI CTEP For the Month of December

December 30, 2011

In Brief: Million, Donaldson Head ASTRO; James Weese Moves To Presbyterian; Ginder Replaces Kennedy

November 9, 1990

St. Jude Begins $100 Million Expansion Program

December 4, 1987

In Brief: Cancer Control Working New Review Guidelines: President Asks Congress For Cigarette Regulation

August 15, 1975

Economic Analysis Finds Erlotinib Marginally Cost-Effective For NSCLC

February 26, 2010

FDA Committee nixes Combination Guidelines, Okays New NDA Policy

January 21, 1977